FMR-2: Regenerative Exosome & EV Therapeutics

Extracellular vesicles and exosome-related technologies are attracting attention across regenerative medicine, but clinicians need a clear understanding of the underlying science and the limits of current evidence. Developed in partnership with NuvoCell Biologics, FMR-2 examines vesicle biology, cell-signaling pathways, biologic classifications, formulation and handling concepts, and the professional considerations surrounding this emerging area. The curriculum includes discussion of real-world product and practice contexts, but the educational focus remains on understanding the science, interpreting claims, and asking better questions. NuvoCell's role is credited transparently without presenting its products as independently validated treatments. This course provides continuing professional education; it does not confer treatment authorization or establish that any product is approved to treat a medical condition.